[Ip-health] GTPI documents on new Brazilian AIDS policy and Voluntary License of Atazanavir
pedro at abiaids.org.br
Tue Mar 11 14:19:14 PDT 2014
I would like to share two position papers recently published by the Working
Group on Intellectual Property (GTPI, acronym in Portuguese), in Brazil.
The first one reffers to the new Test and Treat policy annouced by
Brazilian AIDS Programm and at the same time welcomes the policy and raises
concerns about the universal programm sustainability.
It can be find here: http://goo.gl/yS9vvS
The second one is about the atazanavir voluntary license signed by
Brazilian public laboratory Farmanguinhos and the transnational company
BMS. It brings some worrisome provision identified by GTPI and a brief
evaluation on the contract terms.
It can be find here: http://goo.gl/puXV6Y
Comments and thoughts are very welcome.
Working Grup on Intellectual Property - GTPI/REBRIP
Associação Brasileira Interdisciplinar de AIDS - ABIA
Av. Presidente Vargas, 446/13° andar - Centro
Rio de Janeiro - RJ
tel 21 2223-1040 - fax 21 2253-8495
More information about the Ip-health